drugset / Trial / NCT05561257
Vitamin C as add-on Therapy in Patients With Acute Herpes Zoster
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To compare the efficacy and tolerability of three different doses of Pascorbin® besides standard medication with placebo and the reduction of herpes zoster-associated clinical symptoms as an add-on therapy for patients suffering from acute herpes zoster in primary care
Timeline
- Start
- 2020-07-20
- Primary completion
- 2024-02-28
- Completion
- 2024-02-28
Outcome
Outcome not reported
Stopped (Enrollment): “the necessary recruitment was no longer ensured and fundamental changes in the medical care of herpes zoster, which prevented the original research objectives and the feasibility of the study in the planned scope from being achieved”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin C | Other / unclassified | 750 mg | — |
| Subject | Vitamin C | Other / unclassified | 7.5 g | — |
| Subject | Vitamin C | Other / unclassified | 15 g | — |